Patents by Inventor Joseph Schrevel

Joseph Schrevel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of diagnosing a plasmodium infection
    Patent number: 8709741
    Abstract: The present disclosure provides in vitro methods of diagnosing a Plasmodium infection in a subject. The methods include measuring the serum concentration of at least one secreted phospholipase A2 selected from the group consisting of GIIF, GV and GX sPLA2s, in a blood sample from the subject. The disclosure also relates to a kit for carrying out the disclosed methods and pharmaceutical compositions comprising a recombinant mammalian GIIF, GV or GX sPLA2, or a combination thereof.
    Type: Grant
    Filed: December 3, 2010
    Date of Patent: April 29, 2014
    Assignees: Centre National de la Recherche Scientifique, Universite de Nice Sophia Antipolis, Museum National d'Histoire Naturelle
    Inventors: Christiane Deregnaucourt, Gérard Lambeau, Carole Guillaume, Joseph Schrevel
  • Use of Secreted Phospholipases A2 in the Diagnosis and Treatment of Malaria
    Publication number: 20120282238
    Abstract: The present invention relates to an in vitro method of diagnosis of a Plasmodium infection in a subject, by measuring the serum concentration of at least one secreted phospholipase A2 selected from the group consisting of GIIF, GV and GX sPLA2s, in said subject, from a blood sample. It also relates to a kit for carrying out said method and pharmaceutical compositions comprising a recombinant mammal GIIF, GV or GX sPLA2 or a combination thereof.
    Type: Application
    Filed: December 3, 2010
    Publication date: November 8, 2012
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, MUSEUM NATIONAL D'HISTOIRE NATURELLE, UNIVERSITE DE NICE SOPHIA ANTIPOLIS
    Inventors: Christiane Deregnaucourt, Gérard Lambeau, Carole Guillaume, Joseph Schrevel
  • Method for intensive, in vitro culture of Babesia divergens strains
    Patent number: 5290688
    Abstract: Method for the culture of Babesia divergens, characterized in that the Babesia strain is maintained under culture in a culture medium free from serous protein but containing lipoproteins and red blood corpuscles, and a method for preparing exoantigens and a vaccine containing these antigens.
    Type: Grant
    Filed: October 17, 1991
    Date of Patent: March 1, 1994
    Assignee: Rhone Merieux
    Inventors: Joseph Schrevel, Andre Gorenflot, Eric Precigout, Alain Marchand, Philippe Brasseur, Monique L'Hostis, Daniel Rigomier, Alexis Valentin, Emmanuel Vidor, Guy Bissuel